EPCLUSA TABLET 400MG/100MG
Product details
Registration number: SIN15351P
Classification: Prescription Only
Active ingredients:
- Sofosbuvir
- Velpatasvir
Strength:
- 400mg
- 100mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
ATC code: J05AP55
HSA approval date: 19 October 2017
Manufacturer(s):
- Hovione FarmaCiencia, S.A. (Drug product intermediate)
- Hovione Limited (Drug product intermediate)
- Patheon Inc.
- Gilead Sciences Ireland UC
- Esteve Quimica S.A. (Drug product intermediate)
Manufacturing country/countries: CANADA; SPAIN; PORTUGAL; IRELAND
What are the HSA registration number and classification for EPCLUSA TABLET 400MG/100MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15351P
Classification: Prescription Only
What active ingredients and strength are recorded for EPCLUSA TABLET 400MG/100MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Sofosbuvir
- Velpatasvir
Strength:
- 400mg
- 100mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for EPCLUSA TABLET 400MG/100MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for EPCLUSA TABLET 400MG/100MG?
According to the HSA dataset updated 7 August 2026:
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for EPCLUSA TABLET 400MG/100MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Hovione FarmaCiencia, S.A. (Drug product intermediate)
- Hovione Limited (Drug product intermediate)
- Patheon Inc.
- Gilead Sciences Ireland UC
- Esteve Quimica S.A. (Drug product intermediate)
Manufacturing country/countries: CANADA; SPAIN; PORTUGAL; IRELAND
Where can I look up EPCLUSA TABLET 400MG/100MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15351P or the exact product name EPCLUSA TABLET 400MG/100MG. The general register link does not preselect this product.
What are the source dates for this EPCLUSA TABLET 400MG/100MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this EPCLUSA TABLET 400MG/100MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15351P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)